Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers

被引:171
作者
Geering, Barbara
Cutillas, Pedro R.
Nock, Gemma
Gharbi, Severine I.
Vanhaesebroeck, Bart
机构
[1] Ludwig Inst Canc Res, London W1W 7BS, England
[2] UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England
关键词
quantitative mass spectrometry; signaling; protein stability; gene knockout; lipid kinase;
D O I
10.1073/pnas.0700373104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Class IA phosphoinositide 3-kinases (PI3Ks) signal downstream of tyrosine kinases and Ras and control a wide variety of biological responses. In mammals,these heterodimeric PI3Ks consistof a p110 catalytic subunit (p110 alpha, p110 beta, or p110 delta) bound to any of five distinct regulatory subunits (p85 alpha, p85 beta, p55 gamma, p55 alpha, and p50 alpha, collectively referred to as "p85s"). The relative expression levels of p85 and p110 have been invoked to explain key features of PI3K signaling. For example, free (i.e., non-p110-bound) p85a has been proposed to negatively regulate PI3K signaling by competition with p85/p110 for recruitment to phosphotyrosine docking sites. Using affinity and ion exchange chromatography and quantitative mass spectrometry, we demonstrate that the p85 and p110 subunits are present in equimolar amounts in mammalian cell lines and tissues. No evidence for free p85 or p110 subunits could be obtained. Cell lines contain 10,000-15,000 p85/p110 complexes per cell, with p110 beta and p110 delta being the most prevalent catalytic subunits in nonleukocytes and leukocytes, respectively. These results argue against a role of free p85 in PI3K signaling and provide insights into the nonredundant functions of the different class IA PI3K isoforms.
引用
收藏
页码:7809 / 7814
页数:6
相关论文
共 48 条
  • [1] Essential role for the p110δ phosphoinositide 3-kinase in the allergic response
    Ali, K
    Bilancio, A
    Thomas, M
    Pearce, W
    Gilfillan, AM
    Tkaczyk, C
    Kuehn, N
    Gray, A
    Giddings, J
    Peskett, E
    Fox, R
    Bruce, I
    Walker, C
    Sawyer, C
    Okkenhaug, K
    Finan, P
    Vanhaesebroeck, B
    [J]. NATURE, 2004, 431 (7011) : 1007 - 1011
  • [2] Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards
    Barnidge, DR
    Dratz, EA
    Martin, T
    Bonilla, LE
    Moran, LB
    Lindall, A
    [J]. ANALYTICAL CHEMISTRY, 2003, 75 (03) : 445 - 451
  • [3] Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110α and p110β catalytic subunits of class-Ia phosphoinositide 3-kinases
    Beeton, CA
    Chance, EM
    Foukas, LC
    Shepherd, PR
    [J]. BIOCHEMICAL JOURNAL, 2000, 350 : 353 - 359
  • [4] Key role of the p110δ isoforrn of PI3K in B-cell antigen and IL-4 receptor signaling:: comparative analysis of genetic and pharmacologic interference with p110δ function in B cells
    Bilancio, A
    Okkenhaug, K
    Camps, M
    Emery, JL
    Ruckle, T
    Rommel, C
    Vanhaesebroeck, B
    [J]. BLOOD, 2006, 107 (02) : 642 - 650
  • [5] Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice
    Brachmann, SM
    Ueki, K
    Engelman, JA
    Kahn, RC
    Cantley, LC
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (05) : 1596 - 1607
  • [6] CARPENTER CL, 1993, J BIOL CHEM, V268, P9478
  • [7] p110 delta, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes
    Chantry, D
    Vojtek, A
    Kashishian, A
    Holtzman, DA
    Wood, C
    Gray, PW
    Cooper, JA
    Hoekstra, MF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (31) : 19236 - 19241
  • [8] P50α/p55α phosphoinositide 3-kinase knockout mice exhibit enhanced insulin sensitivity
    Chen, D
    Mauvais-Jarvis, F
    Bluher, M
    Fisher, SJ
    Jozsi, A
    Goodyear, LJ
    Ueki, K
    Kahn, CR
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (01) : 320 - 329
  • [9] Phosphatidylinositol-3-OH kinases are Rab5 effectors
    Christoforidis, S
    Miaczynska, M
    Ashman, K
    Wilm, M
    Zhao, LY
    Yip, SC
    Waterfield, MD
    Backer, JM
    Zerial, M
    [J]. NATURE CELL BIOLOGY, 1999, 1 (04) : 249 - 252
  • [10] A crucial role for the p110δ subunit of phosphatidylinositol 3-kinase in B cell development and activation
    Clayton, E
    Bardi, G
    Bell, SE
    Chantry, D
    Downes, CP
    Gray, A
    Humphries, LA
    Rawlings, D
    Reynolds, H
    Vigorito, E
    Turner, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (06) : 753 - 763